MedTrace Logo

The Liver in the World Trade Center Health Program General Responder Cohort and Controls

NCT03858920 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 340

Last updated 2021-07-12

No results posted yet for this study

Summary

This project investigates whether exposure to the World Trade Center Attack is a risk factor for liver injury.

Conditions

  • Steatosis of Liver
  • NASH - Nonalcoholic Steatohepatitis

Interventions

DEVICE

Fibroscan of Liver

A non-invasive diagnostic device used to measure liver scarring

PROCEDURE

Low-dose non-contrast CT

CT scan as part of routine research care

Sponsors & Collaborators

Principal Investigators

  • Andrea Branch, PhD · Icahn School of Medicine at Mount Sinai

Eligibility

Min Age
55 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-08
Primary Completion
2021-06-11
Completion
2021-06-11
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03858920 on ClinicalTrials.gov